1. Home
  2. HRL vs RNA Comparison

HRL vs RNA Comparison

Compare HRL & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

N/A

Current Price

$22.77

Market Cap

13.5B

ML Signal

N/A

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

N/A

Current Price

$14.62

Market Cap

227.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRL
RNA
Founded
1891
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
227.6M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
HRL
RNA
Price
$22.77
$14.62
Analyst Decision
Buy
Buy
Analyst Count
6
20
Target Price
$27.33
$69.26
AVG Volume (30 Days)
4.3M
2.5M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
5.08%
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$12,106,160,000.00
N/A
Revenue This Year
$2.82
$88.12
Revenue Next Year
$1.90
$18.11
P/E Ratio
$69.77
N/A
Revenue Growth
1.55
N/A
52 Week Low
$21.03
$13.06
52 Week High
$32.07
$73.06

Technical Indicators

Market Signals
Indicator
HRL
RNA
Relative Strength Index (RSI) 35.42 5.77
Support Level $22.24 $13.06
Resistance Level $24.92 $72.52
Average True Range (ATR) 0.63 0.94
MACD -0.25 -2.87
Stochastic Oscillator 0.14 2.63

Price Performance

Historical Comparison
HRL
RNA

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: